Skip to main content
Equibles
GDRX logo

GDRX · GoodRx Holdings, Inc. · Earnings Call Transcripts & Audio

Track GDRX — free

Use GDRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GDRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.23 -0.06 (-1.82%)
Rebalance outlook locked
Market Cap
$1.14B
Shares
341.15M
Volume · Oct 1 313.22K Avg daily vol (3M) 1.3M

GoodRx Holdings, Inc. Earnings Call Transcripts

Quarterly earnings calls for GoodRx Holdings, Inc. (GDRX), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼4% $187.32M −$41.73M '22 Q3 22-11-08 ▼13.7% $184.11M −$1.97M '22 Q4 23-02-28 ▼9.5% $183.99M −$3.29M '23 Q1 23-04-25 ▼1.1% $189.68M $58.79M '23 Q2 23-08-09 ▼3.9% $179.96M −$38.49M '23 Q3 23-11-09 ▲6.8% $196.64M −$25.87M '23 Q4 24-02-29 ▲7.6% $197.88M −$1.01M '24 Q1 24-05-09 ▲5.8% $200.61M $6.69M '24 Q2 24-08-08 ▲8.5% $195.25M $3.96M '24 Q3 24-11-07 ▲1% $198.58M $6.74M '24 Q4 25-02-27 ▲2.6% $202.97M $11.05M '25 Q1 25-05-08 ▲1.2% $203.07M $12.84M '25 Q2 25-08-07 ▲0.4% $196.03M $1.12M '25 Q3 25-11-05 ▼1.9% $194.78M $5.42M '25 Q4 26-02-26 ▼4.4% $194.01M $1.17M '26 Q1 26-05-07 LATEST ▼1.3% $200.41M $8.54M '26 Q2 26-08-06
Earnings call
FY26 · Q2
2026-08-06
GoodRx Holdings, Inc. (GDRX) Q2 2026 Earnings Call Transcript
Confident tone GLP-1 access and demand PharmaDirect growth CFO transition
Revenue
$200.41M
▼ 1.3% YoY
Diluted EPS
$0.02
▼ 50% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
GoodRx Holdings, Inc. (GDRX) Q1 2026 Earnings Call Transcript
Positive tone TrumpRx integration and incremental volume Subscription and weight loss offering PharmaDirect growth and scale
Revenue
$194.01M
▼ 4.4% YoY
Diluted EPS
$0.00
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
GoodRx Holdings, Inc. (GDRX) Q4 2025 Earnings Call Transcript
Confident tone Pharma Manufacturer Solutions / Pharma Direct Consumer Reach and Engagement TrumpRx Partnership
Revenue
$194.78M*
▼ 1.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-05
GoodRx Holdings, Inc. (GDRX) Q3 2025 Earnings Call Transcript
Positive tone Pharma Manufacturer Solutions growth Policy environment / TrumpRx & MFN Kroger RxSmartSaver / retail partnerships
Revenue
$196.03M
▲ 0.4% YoY
Diluted EPS
$0.00
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
GoodRx Holdings, Inc. (GDRX) Q2 2025 Earnings Call Transcript
Positive tone Integrated Savings Program (ISP) headwinds Pharma manufacturer solutions growth Retail and prescription marketplace partnerships
Revenue
$203.07M
▲ 1.2% YoY
Diluted EPS
$0.04
▲ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
GoodRx Holdings, Inc. (GDRX) Q1 2025 Earnings Call Transcript
Positive tone Prescription marketplace and pharmacy partnerships Rite Aid bankruptcy Pharma Manufacturer Solutions and GLP-1 opportunity
Revenue
$202.97M
▲ 2.6% YoY
Diluted EPS
$0.03
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
GoodRx Holdings, Inc. (GDRX) Q4 2024 Earnings Call Transcript
Confident tone Healthcare professional workflow tools and technology Integrated Savings Program (ISP) and direct contracting GLP-1 supply, demand, and pricing opportunity
Revenue
$198.58M*
▲ 1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
GoodRx Holdings, Inc. (GDRX) Q3 2024 Earnings Call Transcript
Positive tone Integrated Savings Program (ISP) Pharma manufacturer solutions / brand growth Adjusted EBITDA performance
Revenue
$195.25M
▲ 8.5% YoY
Diluted EPS
$0.01
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
GoodRx Holdings, Inc. (GDRX) Q2 2024 Earnings Call Transcript
Cautious tone Retail pharmacy store closures Integrated Savings Program (ISP) Pharma manufacturer solutions
Revenue
$200.61M
▲ 5.8% YoY
Diluted EPS
$0.02
▼ 85.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-09
GoodRx Holdings, Inc. (GDRX) Q1 2024 Earnings Call Transcript
Positive tone Integrated Savings Program (ISP) Pharma Manufacturer Solutions Retail direct contracting shift
Revenue
$197.88M
▲ 7.6% YoY
Diluted EPS
$0.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-29
GoodRx Holdings, Inc. (GDRX) Q4 2023 Earnings Call Transcript
Positive tone Retail pharmacy partnerships / hybrid model Integrated savings program (ISP) for commercial plans 2024 financial outlook
Revenue
$196.64M*
▲ 6.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-09
GoodRx Holdings, Inc. (GDRX) Q3 2023 Earnings Call Transcript
Revenue
$179.96M
▼ 3.9% YoY
Diluted EPS
$-0.09
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
GoodRx Holdings, Inc. (GDRX) Q2 2023 Earnings Call Transcript
Revenue
$189.68M
▼ 1.1% YoY
Diluted EPS
$0.14
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-04-25
GoodRx Holdings, Inc. (GDRX) Q1 2023 Earnings Call Transcript
Revenue
$183.99M
▼ 9.5% YoY
Diluted EPS
$-0.01
▼ 133.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
GoodRx Holdings, Inc. (GDRX) Q4 2022 Earnings Call Transcript
Revenue
$184.11M*
▼ 13.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
GoodRx Holdings, Inc. (GDRX) Q3 2022 Earnings Call Transcript
Revenue
$187.32M
▼ 4% YoY
Diluted EPS
$-0.10
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
GoodRx Holdings, Inc. (GDRX) Q2 2022 Earnings Call Transcript
Revenue
$191.80M
▲ 8.6% YoY
Diluted EPS
$0.00
▼ 100% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-09
GoodRx Holdings, Inc. (GDRX) Q1 2022 Earnings Call Transcript
Revenue
$203.33M
▲ 26.7% YoY
Diluted EPS
$0.03
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-28
GoodRx Holdings, Inc. (GDRX) Q4 2021 Earnings Call Transcript
Revenue
$213.26M*
▲ 38.9% YoY
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-10
GoodRx Holdings, Inc. (GDRX) Q3 2021 Earnings Call Transcript
Revenue
$195.10M
▲ 38.9% YoY
Diluted EPS
$-0.04
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
GoodRx Holdings, Inc. (GDRX) Q2 2021 Earnings Call Transcript
Revenue
$176.63M
▲ 43.3% YoY
Diluted EPS
$0.07
▼ 12.5% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
GoodRx Holdings, Inc. (GDRX) Q1 2021 Earnings Call Transcript
Revenue
$160.43M
▲ 20.3% YoY
Diluted EPS
$0.00
▼ 100% YoY
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-11
GoodRx Holdings, Inc. (GDRX) Q4 2020 Earnings Call
Revenue
$153.54M*
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-12
GoodRx Holdings, Inc. (GDRX) Q3 2020 Earnings Call Transcript
Revenue
$140.45M
▲ 38% YoY
Diluted EPS
$-0.21
▼ 520% YoY
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–24 of 24 earnings calls
Key facts CIK 1809519 CUSIP 38246G108 13F (30d) 5 filings 5 filers Visit website Investor relations